Nephrotic syndrome diagnostic study of choice

	Nephrotic Syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Nephrotic syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X-Ray
Echocardiography or Ultrasound
CT Scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Nephrotic syndrome diagnostic study of choice On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Nephrotic syndrome diagnostic study of choice All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Nephrotic syndrome diagnostic study of choice
CDC on Nephrotic syndrome diagnostic study of choice
Nephrotic syndrome diagnostic study of choice in the news
Blogs on Nephrotic syndrome diagnostic study of choice
Directions to Hospitals Treating Nephrotic syndrome
Risk calculators and risk factors for Nephrotic syndrome diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Kidney biopsy is the gold standard test for the diagnosis of nephrotic syndrome.^[1]
This method will reveal the exac cause of proteinuria.

Relative contrandications are:

↑ "Clinical competence in percutaneous renal biopsy. Health and Public Policy Committee. American College of Physicians". Ann. Intern. Med. 108 (2): 301–3. February 1988. PMID 3341661.